Medtech startup In-Med secures funding from Exxora, others

11:00:00 PM, Monday 12th of December 2022 | in startups

Medtech startup In-Med Prognostics has raised $2.13 Mn in an equity, seed funding round led by Exxora Trading LLP along with other angel investors. Including the current fundraising, In-Med has raised a total of $2.6 Mn to date. Founded in 2018 by Latha Poonamallee, Rajesh Purushottam and Al Curran, In-Med offers AI-enabled image-processing software that helps radiologists and neurologists in assessing reports.